Business
Applied BioSciences Provides Corporate Update and 2019 Business Outlook
Applied BioSciences Provides Corporate Update and 2019 Business Outlook.
About this update from Applied Biosciences Corp.
[{"type":"text","content":"Key Management appointments, including Raymond W. Urbanski MD, PhD, former business unit Chief Medical Officer at Pfizer Inc., as Chief Executive Officer provides extensive industry leading expertise, strategic focus and discipline on the execution of corporate initiativesPurposefully built strategic business units focused on leveraging science-driven cannabinoid research to address areas of significant unmet needs and access growing marketsMultiple expected near-term value driving milestonesBEVERLY HILLS, CA / ACCESSWIRE / July 30, 2019 / Applied BioSciences Corp. (OTCQB: APPB) ("Applied" or the "Company"), a vertically integrated company focused on the development of science-driven cannabinoid biopharmaceuticals and the production of high-quality CBD products, today provided a corporate update and business outlook for the remainder of 2019. Corporate HighlightsRenewed strategy focused on leveraging endocannabinoid system to develop high-value products across three separate business units, including:Biopharmaceuticals: goal to develop novel therapeutics to treat serious diseases across a range of therapeutic areas, including metabolic, peripheral neuropathy and progressive lung disease CBD Products: multiple brands offering high-quality CBD products to the highest regulatory standards;Bolstered leadership team with highly qualified individuals including Raymond W. Urbanski MD, PhD, as Chief Executive Officer, former business unit Chief Medical Officer at Pfizer Inc. and well-established industry leading expert with over 20 years of experience in clinical development, research and pharmaceutical industry expertise across oncology, cardiology, endocrinology, and immunology;Appointed Martin Schroeder to the Scientific Advisory Board and as President of Applied BioPharma. Mr. Schroeder has over 30 years of experience in the pharmaceutical and biotech industries and has helped many biotech and pharmaceutical companies conduct search and evaluation of compounds and molecules;Launched multiple new products and expanded into the Beverage and Health / Wellness category with Remedi Spa and Remedi Beverage and Shot;Commenced discussions regarding proposed scientific trials with two leading Universities specializing in Veterinary Medicine;Announced the acquisition of Trace Analytics with over 65 years of combined experi...